Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Comment by tradingsteveon Aug 17, 2010 7:18pm
603 Views
Post# 17359209

RE: Dean et Al. know what Big Pharmas

RE: Dean et Al. know what Big Pharmassome good food for thought here.....it's truly unfortunate that potash was more widely discussed on this board than this comment

CJ......please keep me (if no one else wants to ask or comment) informed of any luck you have with finding the MRS endpoints from the past trial.......you certainly provide some points to ponder..... and with the alleged insider buying going on, maybe there is much more to this one than meets the eye.....

as well do i take it from the end of your post that Excelsior (ELE) is a company you are following as well?....no one else is sticking to SSS on here, so i figured i'd ask
Bullboard Posts